Healthcare Sales & Marketing Network News: Exforge

Searching News Database: Exforge

HSMN NewsFeed - 28 Jan 2009
Ipsen announces the signature of a co-promotion agreement with Novartis for Exforge in France
Biopharmaceuticals

HSMN NewsFeed - 15 Oct 2007
Sepracor Announces Senior Management Appointments as Part of Commercial Re-Organization
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2007
Exforge(R) Receives Final US Approval as New and Powerful Treatment Option for Patients With High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Dec 2006
Exforge(R) Receives US Regulatory Approval as a New and Highly Effective Treatment Option for Patients with High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 17 May 2006
Novartis Announces Efficacy Data on New Investigational High Blood Pressure Therapies at The American Society of Hypertension Annual Meeting
Biopharmaceuticals

HSMN NewsFeed - 1 May 2006
FDA Approves Higher Dose Formulations of Diovan HCT(R) (valsartan/hydrochlorothiazide) for Treatment of High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Apr 2006
US Submission of Exforge(R) Accepted for Review by the FDA as a New Therapy Option for High Blood Pressure
Biopharmaceuticals FDA

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.